Apple Inc.

Apple's Q2 FY26 marks the second consecutive quarter of double-digit consolidated growth, with total revenue of $111.2B up 17% year-over-year. Sequentially, revenue stepped down from the Q1 FY26 all-time record of $143.8B to $111.2B — a roughly $32.6B decline that reflects the normal post-holiday seasonality between the December and March quarters rather than any deterioration in underlying demand. On a year-over-year basis, the 17% Q2 growth rate moderated only modestly from Q1's +16%, so the growth cadence held firm across the first half.

iPhone is the dominant driver. Q2 iPhone revenue reached a March-quarter record of $57.0B, up 22% year-over-year from $46.8B in Q2 FY25. That +22% pace sits just below the +23% Q1 FY26 figure when iPhone delivered $85.3B, confirming that the iPhone 17 family's strength persisted beyond the holiday launch quarter; management noted the lineup is the most popular in its history through the March quarter and that it gained share per IDC. Services posted an all-time record of $31.0B, up 16% year-over-year from $26.6B, an acceleration versus the +14% Services growth in Q1 FY26 ($30.0B) — a constructive sign for the highest-margin segment.

The smaller hardware lines grew but at more modest rates. Mac revenue was $8.4B, up 6% year-over-year from $7.9B, decelerating from the +13% pace in Q1 FY26. iPad revenue was $6.9B, up 8% year-over-year from $6.4B, a sharp deceleration from the +23% in Q1 FY26 when iPad benefited from a refresh cycle. Wearables, Home and Accessories returned to growth at $7.9B, up 5% year-over-year from $7.5B — a notable improvement versus the -3% decline the segment posted in Q1 FY26, supporting the recovery thesis for that category.

On profitability, gross margin expanded to 49.3% in Q2 FY26 from 48.2% in Q1 FY26, a roughly 110bp sequential step-up, helped by the richer Services mix. Operating income was $35.9B at a ~32.3% operating margin, down sequentially from $49.6B and a ~34.5% margin in Q1 FY26 on the lower seasonal revenue base; the margin compression is driven principally by stepped-up operating expense rather than gross-margin erosion. R&D expense rose to $11.4B, up 33.6% year-over-year, a marked acceleration in investment intensity versus the $8.3B (+19% YoY) reported in Q1 FY26, signaling reinvestment ahead of the product roadmap management repeatedly emphasized. SG&A was $7.5B, broadly stable versus $7.2B in Q1 FY26.

Net income was $29.6B, up 19% year-over-year from $24.8B, down sequentially from the $42.1B Q1 FY26 figure on seasonality. Diluted EPS of $2.01 set a March-quarter record, up 22% year-over-year from $1.65, versus the $2.84 reported in Q1 FY26. On capital allocation, operating cash flow was $28.7B in Q2, down from the record $53.9B in Q1 FY26 — again the typical Q2-versus-Q1 holiday pattern. The company repurchased $12.6B of stock and paid $3.8B in dividends ($0.26/share) in Q2, a step down from $25.0B of buybacks and $3.9B of dividends in Q1 FY26, consistent with lower seasonal cash generation. Share count declined to 14.8B from 15.1B, modestly accretive to EPS.

Geographically, the mix shifted sequentially with seasonality but every region grew double digits year-over-year per management. Americas was $45.1B in Q2 versus $58.5B in Q1 FY26, Europe $28.1B versus $38.1B, Greater China $20.5B versus $25.5B, Japan $8.4B versus $9.4B, and Rest of Asia Pacific $9.1B versus $12.1B. The standout is Greater China, which management flagged as posting strong double-digit growth in Q2 after a +38% year-over-year surge in Q1 FY26, supporting the China-recovery narrative that has anchored recent quarters. Compared with the year-ago March quarter, Greater China at $20.5B is well above the $15.4B Q3 FY25 and $14.5B Q4 FY25 readings, underscoring the reacceleration.

Versus expectations, Q2 FY26 actual EPS of $2.01 beat the $1.95 consensus estimate, extending an unbroken run of beats across the last eight quarters — including the $2.85 versus $2.67 beat in the prior quarter and $1.85 versus $1.73 two quarters back. Management has consistently delivered above the Street, reinforcing credibility. On insider activity, the trailing-90-day window shows net insider selling (Form 4 / Section 16) of $147.5M across 35 dispositions against negligible acquisitions, a more pronounced net-selling posture than routine; the largest contributor was director Arthur Levinson, who sold $86.74M across five dispositions (Form 4 / Section 16). Relative to Sentia's prior assessment, the drift score and Strengthening status are held at 80, consistent with the prior reading, with themes spanning iPhone strength, Services momentum, Wearables recovery, margin expansion, R&D intensity, the CEO transition, and Greater China recovery all carrying forward and broadly confirmed by the Q2 data.

Apple's Q2 FY26 sits within a constructive external framing. No peer or sector comparison data was provided in the sources, so this section does not assert relative positioning against named competitors; the market read is built primarily on analyst consensus, geographic exposure, and the earnings-surprise record.

Analyst sentiment is decidedly positive. The consensus label is Buy, with 70 Buy-side ratings (1 Strong Buy and 69 Buy) against 33 Hold and 7 Sell and no Strong Sell ratings. The price-target consensus is $326.47, with a median of $325, a high of $400, and a low of $253 — a spread that brackets the recent trading range implied by insider sale prices in the $251-$311 band (Form 4 / Section 16). The breadth of Buy ratings relative to Hold and Sell signals that the Street largely endorses the same momentum story management is telling, corroborating the high narrative drift score.

Forward consensus models continued multi-year growth, with average revenue estimates of $483.1B for FY2029 and $662.3B for FY2030, alongside EPS estimates of $11.79 and $12.82 respectively. These are third-party expectations, not Sentia forecasts, but they indicate the market is underwriting durable compounding consistent with the reinvestment intensity visible in the rising R&D line.

Geographically, the name remains concentrated in the Americas at $45.1B of Q2 segment revenue, followed by Europe at $28.1B and Greater China at $20.5B. Greater China is the most macro-sensitive exposure and the one management has leaned on as a recovery narrative; its return to strong double-digit growth reduces, but does not eliminate, the regional risk that has historically swung the stock. Emerging-market strength, including double-digit growth in India, broadens the geographic base.

The earnings-surprise record reinforces the market's confidence: Apple beat consensus EPS again in Q2 at $2.01 versus $1.95, extending a streak of beats across the last eight quarters. With a Buy-tilted rating distribution, a price-target midpoint above recent levels, and a consistent beat history, the market is pricing essentially the same story management is articulating. The principal divergence to monitor is the notable net insider selling (Form 4 / Section 16) and the leadership transition, which the analyst consensus has not yet flagged as a thesis-changer — keeping the narrative drift score at 80, where management's optimism and the reported fundamentals remain tightly aligned.